Company news

OncoZenge AB news in 2025

OncoZenge AB's news releases, calls and decks from 2025, newest first.

View company

OncoZenge advances BupiZenge with CTA submission and 9,1 MSEK funding tranche

December 19, 2025

OncoZenge resolves on a directed share issue to Sichuan Yangtian Bio-Pharmaceutical pursuant to existing investment agreement

December 19, 2025

OncoZenge Submits Clinical Trial Application for Pivotal Phase III Trial (BZ003) of BupiZenge™

December 18, 2025

OncoZenge AB Enters into Collaboration with UCLA for Patient Engagement Study on BupiZenge™

September 17, 2025